Bayban’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$90.9K Hold
432
– – 0.07% 179
2026
Q2
$82.2K Hold
432
– – 0.06% 183
2026
Q1
$72.9K Hold
432
– – 0.06% 196
2025
Q4
$72.9K Buy
+432
New +$70.2K 0.06% 188

Other funds holding IBB

Bayban's IBB Position: Q3 2026 in Review

Bayban held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 432 shares worth $90.9K. The position accounts for 0.07% of the portfolio, ranked #179.

Bayban first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Bayban held 432 shares of iShares Biotechnology ETF worth $90.9K as of Q3 2026.
  • Bayban left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.07% of Bayban's portfolio in Q3 2026, its #179 holding.
  • Bayban first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
  • 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.